,outcome,arm 1,arm 2
0,intervention,amantadine-treated group,placebo
0,absolute changes in clinician-rated ABC-CVs for hyperactivity,-1.9,NR
0,"absolute changes in clinician-rated ABC-CVs for hyperactivity, inappropriate speech",NR,"-2.1, 0.4"
